Prelude Therapeutics shares owned by Massachusetts Financial Services
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Massachusetts Financial Services
from 13F filings
Historical chart of Massachusetts Financial Services investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Massachusetts Financial Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Massachusetts Financial Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.4M | 508k | 4.74 |
| 2023-12-31 | $2.2M | 511k | 4.27 |
| 2023-09-30 | $1.6M | 510k | 3.09 |
| 2023-06-30 | $2.3M | 509k | 4.50 |
| 2023-03-31 | $2.9M | 515k | 5.70 |
| 2022-12-31 | $3.1M | 515k | 6.04 |
| 2022-09-30 | $3.4M | 513k | 6.61 |
| 2022-06-30 | $2.5M | 479k | 5.22 |
| 2022-03-31 | $3.3M | 482k | 6.90 |
| 2021-12-31 | $5.8M | 469k | 12.45 |
| 2021-09-30 | $15M | 472k | 31.25 |
| 2021-06-30 | $11M | 375k | 28.63 |
| 2021-03-31 | $12M | 281k | 43.33 |
| 2020-12-31 | $20M | 284k | 71.55 |
| 2020-09-30 | $16M | 518k | 30.13 |
More positions owned by Massachusetts Financial Services
Cigna Corp (CI)
View all positions for Massachusetts Financial Services